Evaluation of the Patient's Experience in Medical Studies for Cholangiocarcinoma

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-02-29

Study Completion Date

2026-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main reason for conducting this research is to gain a better understanding of why some people with cholangiocarcinoma are not able to participate in or complete clinical trials. Historically, certain groups of people have been more likely to participate in clinical trials, but there hasn't been much research to understand why this is the case.

The goal is to find out which aspects of a clinical trial may make it more difficult for patients to take part or see it through. The data will be evaluated through different demographic lenses and identify trends that could help improve the experience of future cholangiocarcinoma patients during clinical trials.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Disease Management Program or Usual Care in Patients With Stage III or Stage IV Lung Cancer, Pancreatic Cancer, Ovarian Cancer, or Colorectal Cancer, and Their Caregivers

NCT00684801

Colorectal Cancer Lung Cancer Ovarian Cancer +1 more

COMPLETED

Evaluating Patient Participation in Phase I Clinical Trials

NCT00043030

Psychosocial Effects of Cancer and Its Treatment Unspecified Adult Solid Tumor, Protocol Specific

COMPLETED NA

Exercise Program During Chemotherapy in Metastatic Colorectal Cancer

NCT03111823

Stage IV Colorectal Cancer

TERMINATED NA

Quality of Life and Development of Measures in Patients With Cancer of the Oral Cavity

NCT00582413

Cancer of the Oral Cavity

COMPLETED

Clinical Trial Navigation to Increase Participation and Diversity in Cancer Clinical Trials

NCT06484595

Hematopoietic and Lymphatic System Neoplasm Malignant Solid Neoplasm

ACTIVE_NOT_RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cholangiocarcinoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CROSSOVER

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient is at least 18 years of age
* Participant has a diagnosis of Cholangiocarcinoma
* Patient has self-identified as planning to enroll in an interventional Cholangiocarcinoma clinical trial
* Patient must provide written informed consent

Exclusion Criteria

* No diagnosis of Cholangiocarcinoma confirmed
* Inability to perform regular electronic reporting
* Women who are pregnant, intend to become pregnant, or are lactating
* Patient does not understand, sign, and return consent form

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No